查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1854046

伽玛刀市场按分销管道、最终用户、应用和产品类型划分－2025-2032年全球预测

Gamma Knife Market by Distribution Channel, End User, Application, Product Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，伽玛刀市场规模将达到 6.4868 亿美元，复合年增长率为 7.09%。

主要市场统计数据
基准年 2024 3.7491亿美元
预计年份：2025年 4.0105亿美元
预测年份：2032年 6.4868亿美元
复合年增长率 (%) 7.09%

本文对伽玛刀放射线手术技术、临床应用以及影响采购和服务模式的商业动态进行了简明扼要的基本概述。

伽玛刀立体定位放射放射线手术仍然是神经外科和放射外科治疗模式中的基石技术，它将亚毫米级的靶向精度与非侵入性治疗相结合，用于治疗复杂的颅内病变。该系列设备涵盖了传统平台和现代平台，它们在光束传输架构、工作流程整合以及辅助成像和计划软体方面存在差异。临床相关人员持续优先考虑那些能够最大限度减少患者固定、优化治疗效率并与涵盖神经外科、放射肿瘤科和神经肿瘤科的多学科治疗流程整合的系统。

在商业性，伽玛刀系统生态系统涵盖了与原始设备製造商 (OEM) 的直接合作协议、分销商关係以及从三级医院到门诊手术中心等各类终端用户。采购偏好和服务合约的趋势反映了以结果为主导的采购模式，其中生命週期服务协议、升级路径和软体价值获取等因素都会影响采购决策。本导论性概述将临床能力、通路动态和产品演进与对医院高阶主管、服务线负责人和商业团队至关重要的策略考量连结起来，为后续分析奠定了基础。

临床进步、工作流程效率提升和不断演变的筹资策略如何重塑放射外科服务的提供者采用和供应商竞争格局

伽玛刀治疗领域正因技术创新、临床路径的演进和商业性模式的改变而改变。立体定位计画演算法的进步、与高解析度磁振造影的整合以及无框架工作流程的出现，拓展了适应症范围，改善了病患体验，促使更多中心将放射线手术作为特定脑部病变的标准治疗方案进行评估。这些临床进展，加上治疗效率和吞吐量的提升（影响治疗的地点和方式），使得伽玛刀治疗得以在传统三级医疗中心之外得到应用。

同时，竞争动态日趋成熟。各种放射学平台和影像导引系统不断涌现，迫使传统产品线展现差异化的临床疗效和营运经济效益。部分地区的支付和报销机制也更重视流程和结果，迫使供应商和医疗机构提供疗效对比和资源利用率的证明。此外，随着医院寻求降低初始资本支出并更好地预测多年总拥有成本，筹资策略也正转向配套服务模式和快速升级路径。

评估累积关税和进口限制如何影响放射线手术系统采购时间、供应商定价策略和供应链韧性

近期关税政策的变化为伽玛刀系统的资本设备规划和供应链弹性带来了新的变数。关税的累积以及相关的进口限制会影响复杂医疗设备、组件和软体硬体升级的到岸成本，进而对供应商的定价策略和设施采购时间产生连锁反应。采购团队正日益将关税情境规划纳入资本核准流程，以确保紧急资金到位，并避免因清关和供应商重新定价而导致的计划延误。

为此，目标商标产品製造商和分销商正在调整商业性策略，包括库存本地化、关键零件供应商多元化，以及提供更灵活的融资和升级即服务选项。虽然长期服务协议和在地化的升级库存可以缓解即时价格衝击，但依赖临时采购的机构可能面临更大的风险。这需要重新重视供应链透明度、明确价格调整的合约条款，并加强采购、临床工程和供应商客户团队之间的协作，以管理实施进度和预算影响。

透过精细化的细分框架，我们可以获得可操作的洞察，该框架展示了管道、最终用户、临床用途和产品模型如何决定市场采纳管道和售后市场需求。

详细的細項分析揭示了不同分销管道、最终用户、应用领域和产品类型在产品采纳驱动因素和商业化管道方面的差异。分销管道动态包括直销模式（包括电子商务倡议和专属OEM销售团队）以及透过区域和全国分销商网路运营的经销商主导管道，每种模式都会影响前置作业时间、服务应对力和捆绑销售机会。最终使用者细分涵盖了从注重简化工作流程的门诊手术中心（包括放射科和外科中心）到拥有综合多学科计画的区域性和三级医疗中心，再到优先考虑特定手术吞吐量和临床结果的专科诊所（例如神经外科中心和肿瘤科诊所）。

基于应用领域的细分突出了脑肿瘤治疗（区分原发性和转移性病变）、功能性疾病（如运动障碍和三叉神经痛）以及血管畸形（包括动静脉畸形和海绵状血管畸形）等方面的独特临床和操作考虑。产品类型细分则反映了传统平台和新型平台的装机量和升级管道，例如4C、Icon、Model C和Perfexion等型号，每种型号都提供新的机器类型销售和升级方案，因此具有不同的装置量模式。

区域法律规范、报销动态和医疗服务提供者基础设施的差异如何影响全球主要地区的采用模式和商业性模式

伽玛刀系统的临床应用模式、法规要求和商业性实施深受区域动态的影响。在美洲，大型学术医疗中心和区域医院系统并存，其报销机制和网路层面的资本规划决定了升级和新设备的部署速度。在手术报销和患者吞吐量支援分散式放射放射线手术服务的地区，门诊治疗模式正日益普及。同时，都市区三级医疗中心仍在持续投资于综合多重模式治疗计画。

在欧洲、中东和非洲，法律规范和国家报销政策造成了营运环境的差异，灵活的商业模式和强大的经销商合作伙伴关係更受青睐，以便应对当地的核准和服务预期。在一些国家，公共医疗采购流程和集中竞标要求提供令人信服的临床和成本效益证据。在亚太地区，主要城市中心的产能快速扩张与新兴市场的定向投资结合。事实证明，本地製造伙伴关係、培训计画和可扩展的服务模式能够有效加速产品推广，同时应对劳动力和基础设施的差异。

为什么产品差异化、卓越的全生命週期服务和通路伙伴关係决定了放射线手术领域的竞争优势和长期供应商合作关係

在伽玛刀及更广泛的立体定位放射线手术市场中，竞争地位取决于产品差异化、全生命週期服务能力和通路执行力的综合考量。领先供应商专注于展示临床精准性、工作流程整合性和长期可维护性，而相邻的竞争对手则致力于提供替代的射线束传输技术和混合治疗方案，以吸引那些寻求多功能平台的医疗机构。原始设备製造商 (OEM) 与医院系统之间的策略伙伴关係日益重视已安装设备的升级、培训以及软体驱动的临床决策支持，以此作为维持长期合作关係的手段。

除了主要製造商之外，服务供应商、影像处理合作伙伴和软体开发商组成的网路在实现临床价值方面也发挥着至关重要的作用。投资于完善的培训体系、远端监控功能和快速的零件供应的公司，能够从已安装的系统中挖掘更多价值，并减少医疗机构的停机时间。此外，为 4C、Icon、Model C 和 Perfexion 等型号提供清晰升级路径的原始设备製造商 (OEM) 和经销商，可延长设备的使用寿命，并提供更可预测的总成本。

供应商和服务商可采取切实可行的策略步骤，协调产品创新、商业性灵活性和服务能力，以加速产品推广应用并降低实施风险。

产业领导者应采取多管齐下的策略，在应对临床、商业性和政策方面的挑战的同时，抓住放射线手术的成长机会。首先，产品蓝图与临床医生的需求保持一致，优先考虑无框架工作流程、增强影像整合和自动化规划，以缩短治疗时间并扩大患者覆盖范围。持续投资于临床证据的产生和同侪审查的结果数据，能够增强采购论证，并支持将其纳入标准化诊疗路径。

其次，我们将优化商业模式，降低关税带来的成本波动，并透过拓展灵活的资金筹措、升级即服务 (UaaS) 和本地化库存策略来缩短部署週期。加强通路伙伴关係：明确直销团队和各国分销商之间的角色分工，以确保服务水准协议的一致性和知识转移的顺利进行。最后，我们将投资于员工赋能和数位化服务能力，例如远端诊断和培训平台，以提高运作，支援新用户快速上手，并加强与客户的长期合作关係。

采用透明的混合方法研究途径，结合相关人员访谈和二手证据综合，以检验临床和商业性见解。

本分析综合运用混合研究途径，结合了对主要相关利益者的访谈和严谨的二手证据综合分析，从而得出相关见解。主要访谈包括与临床负责人、采购专家、临床工程师和供应商客户经理进行结构化访谈和讨论，以了解他们对设备选择标准、工作流程优先顺序和合约偏好的现场观点。这些对话使我们对不同类型医疗机构在实施过程中遇到的障碍、服务期望和升级理由有了定性的了解。

二级研究涵盖了同行评审的临床文献、监管指南、政策公告和公开的产品文​​檔，旨在检验临床性能声明，并将技术发展置于监管框架内进行考察。调查方法包括对一手和二手资料进行交叉检验，以识别共同的主题并确定需要密切关注的领域。透过迭代三角验证来保持分析的严谨性，确保结论能够反映在多个资讯流和相关人员中观察到的一致模式。

一份综合总结报告，重点阐述了策略重点、供应链韧性和证据完整性，以支持永续放射放射线手术的推广应用。

最后，伽玛刀领域正处于曲折点，临床创新、供应链动态和不断演变的采购模式在此交会。积极适应无框架工作流程、投资于可互通的规划和成像解决方案并部署灵活商业模式的医疗服务提供者和供应商，将更有利于抓住新的市场需求并加强长期伙伴关係。关税带来的成本压力凸显了供应链多元化和本地服务能力的重要性，以确保实施时间表和总生命週期成本的可预测性。

展望未来，成功与否取决于临床证据产生与采购方案的契合度、利用细分市场洞察来调整通路和产品策略，以及建构能够保障系统运作并维繫临床医师忠诚度的稳健服务基础设施。将这些因素纳入资本规划和临床策略的医疗机构，将更有利于扩大精准放射放射线手术的覆盖范围，同时保持财务纪律和卓越运作。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 提高无框架立体定位放射外科技术的应用，以提高病患舒适度和工作流程效率
  • 整合人工智慧演算法以实现即时剂量计划和自适应治疗优化
  • 扩大伽玛刀的适应症范围，将三叉神经痛等非恶性神经系统疾病纳入其中。
  • 开发聚焦光束准直技术，以减少健康脑组织受到的辐射暴露
  • 由于成本更低、恢復时间更短，门诊放射线手术越来越受到青睐。
  • 学术中心与製造商合作进行的一项研究倡议，旨在提高精准放射放射线手术的效果。
  • 监管核准和报销改革促进新兴市场更广泛地获得伽玛刀治疗

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 伽玛刀市场依分销管道划分

  • 直销
    • 电子商务
    • OEM销售团队
  • 批发商
    • 当地经销商
    • 全国经销商

9. 以最终用户分類的伽玛刀市场

  • 门诊手术中心
    • 放射中心
    • 手术中心
  • 医院
    • 社区医院
    • 三级医疗机构
  • 专科诊所
    • 神经外科中心
    • 肿瘤诊所

第十章 伽玛刀市场依应用领域划分

  • 脑肿瘤
    • 转移性脑瘤
    • 原发性脑肿瘤
  • 功能障碍
    • 运动障碍
    • 三叉神经痛
  • 血管畸形
    • 动静脉畸形
    • 海绵状血管畸形

第十一章 伽玛刀市场依产品类型划分

  • 4C
    • 新单元
    • 升级
  • Icon
    • 新单元
    • 升级
  • Model C
    • 新单元
    • 升级
  • Perfexion
    • 新单元
    • 升级

第十二章 伽玛刀市场区域划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 伽玛刀市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国伽玛刀市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Elekta AB（publ）
    • Accuray Incorporated
    • Siemens Healthineers AG
    • Varian Medical Systems, Inc.
    • Brainlab AG
    • ViewRay, Inc.
    • Nordion Inc.
    • Mevion Medical Systems, Inc.
    • IBA Group SA
    • Shinva Medical Instrument Co., Ltd.
Product Code: MRR-0D217D5AEF01

The Gamma Knife Market is projected to grow by USD 648.68 million at a CAGR of 7.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 374.91 million
Estimated Year [2025] USD 401.05 million
Forecast Year [2032] USD 648.68 million
CAGR (%) 7.09%

A concise foundational overview of Gamma Knife radiosurgery technology, clinical integration, and commercial dynamics shaping procurement and service models

Gamma Knife stereotactic radiosurgery remains a cornerstone technology in neurosurgical and radiosurgical treatment paradigms, combining sub-millimeter targeting precision with non-invasive delivery to treat complex intracranial pathologies. The device family encompasses legacy and modern platforms that vary by beam delivery architecture, workflow integration, and ancillary imaging and planning software. Clinical stakeholders continue to prioritize systems that minimize patient immobilization, optimize throughput, and integrate with multidisciplinary care pathways spanning neurosurgery, radiation oncology and neuro-oncology.

Commercially, the ecosystem around Gamma Knife systems includes direct OEM engagements, distributor relationships, and diverse end users ranging from tertiary hospitals to ambulatory surgical centers. Shifts in purchasing preferences and service contracting reflect a broader trend toward outcomes-driven procurement, where lifecycle service agreements, upgrade pathways and software-enabled value capture influence acquisition decisions. This introductory synthesis frames the subsequent analysis by linking clinical capability, channel dynamics and product evolution to the strategic considerations that matter to hospital executives, service line leaders and commercial teams.

How clinical advances, workflow efficiencies, and evolving procurement strategies are reshaping provider adoption and vendor competition in radiosurgical services

The Gamma Knife landscape is undergoing transformative shifts driven by technological innovation, evolving clinical pathways and changing commercial arrangements. Advances in stereotactic planning algorithms, integration with high-resolution MRI and the emergence of frameless workflows have broadened indications and improved patient experience, prompting more institutions to evaluate radiosurgery as a standard-of-care option for select brain lesions. These clinical advances have coincided with improvements in throughput and efficiency that influence where and how care is delivered, enabling adoption beyond traditional tertiary centers.

At the same time, competitive dynamics have matured. Competing radiation platforms and image-guided systems have intensified pressure on legacy product lines to demonstrate differentiated clinical outcomes and operational economics. Payment and reimbursement frameworks in several jurisdictions are becoming more procedure- and outcome-focused, compelling vendors and providers to document comparative effectiveness and resource utilization. Additionally, procurement strategies are shifting toward bundled service models and upgrade-first pathways, as hospitals seek to reduce large upfront capital expenditures and better predict total cost of ownership over multi-year horizons.

Assessing how cumulative tariff measures and import controls are influencing procurement timing, vendor pricing strategies, and supply chain resilience for radiosurgery systems

Recent tariff policy developments have introduced a new variable into capital equipment planning and supply chain resilience for Gamma Knife systems. Cumulative duties and associated import controls can affect the landed cost of complex medical devices, componentry and software-linked hardware upgrades, with ripple effects on vendor pricing strategies and institutional procurement timing. Procurement teams are increasingly incorporating tariff scenario planning into their capital approval processes to ensure contingency funding and avoid project delays tied to customs clearance or supplier repricing.

In response, original equipment manufacturers and distributors are adjusting their commercial approaches by localizing inventories, diversifying supplier bases for critical components and offering more flexible financing or upgrade-as-a-service arrangements. Transmission of tariff-related cost pressures to end users varies by contracting structure; long-term service agreements and locally stocked upgrade inventories can mitigate immediate price shocks, while institutions relying on ad-hoc purchasing may experience greater exposure. The combined effect is a re-emphasis on supply chain transparency, contractual clarity on price adjustments and enhanced collaboration between procurement, clinical engineering and vendor account teams to manage implementation timelines and budgetary impact.

Actionable insights from a granular segmentation framework showing how channels, end users, clinical applications, and product models determine adoption pathways and aftermarket demand

Deep segmentation analysis reveals differentiated adoption drivers and commercialization pathways across distribution channels, end users, applications and product types. Distribution channel dynamics include direct sales models, which encompass e-commerce initiatives and dedicated OEM sales teams, and distributor-led channels that operate through local and national distributor networks; each approach affects lead times, service responsiveness and opportunities for bundled offerings. End user segmentation captures a spectrum from ambulatory surgical centers, which include radiology and surgical centers focused on streamlined workflows, to hospitals that span community facilities and tertiary care centers with comprehensive multidisciplinary programs, and specialty clinics such as neurosurgery centers and oncology clinics that prioritize procedure-specific throughput and clinical outcomes.

Application-based segmentation shows distinct clinical and operational considerations for treating brain tumors-differentiating between primary and metastatic lesions-functional disorders such as movement disorders and trigeminal neuralgia, and vascular malformations including arteriovenous and cavernous variants; each indication drives unique planning protocols, imaging requirements and patient selection criteria. Product type segmentation reflects the installed base and upgrade pathways across legacy and modern platforms, with distinct purchase patterns for models including 4C, Icon, Model C and Perfexion, each offering new unit sales and upgrade packages; the interplay between available upgrades and end-user operational priorities significantly shapes replacement cycles and aftermarket service demand.

How regional regulatory frameworks, reimbursement dynamics, and provider infrastructure differences are shaping adoption patterns and commercial approaches across major global regions

Regional dynamics materially influence clinical adoption models, regulatory requirements and commercial execution for Gamma Knife systems. In the Americas, procurement decisions are shaped by a mix of large academic medical centers and community hospital systems, where reimbursement structures and network-level capital planning determine the cadence of upgrades and new installations. Transition to ambulatory settings is gaining traction where procedural reimbursement and patient throughput support decentralized radiosurgery delivery, while urban tertiary centers continue to invest in integrated multimodality programs.

In Europe, the Middle East and Africa, regulatory frameworks and national reimbursement policies create a heterogeneous operating environment that favors flexible commercial models and strong distributor partnerships to navigate local approvals and service expectations. Public healthcare procurement processes and centralized tendering in several countries necessitate compelling clinical and cost-effectiveness evidence. Asia-Pacific regions present a combination of rapid capacity expansion in major metropolitan centers and targeted investments in emerging markets; local manufacturing partnerships, training programs and scalable service models are proving effective to accelerate adoption while addressing workforce and infrastructure variability.

Why product differentiation, lifecycle service excellence, and channel partnerships determine competitive advantage and long-term vendor-provider alignment in radiosurgery

Competitive positioning within the Gamma Knife and broader stereotactic radiosurgery market depends on a combination of product differentiation, lifecycle service capabilities and channel execution. Leading vendors focus on demonstrating clinical precision, workflow integration and long-term serviceability, while adjacent competitors emphasize alternative beam delivery technologies and hybrid treatment offerings that appeal to centers seeking multifunctional platforms. Strategic partnerships between OEMs and hospital systems increasingly emphasize installed-base upgrades, training and software-enabled clinical decision support as levers to sustain long-term relationships.

Beyond headline manufacturers, a network of service providers, imaging partners and software developers plays a crucial role in enabling clinical value. Companies that invest in robust training ecosystems, remote monitoring capabilities and rapid parts distribution can extract additional value from installed systems and reduce downtime for providers. Additionally, OEMs and distributors that offer clear upgrade pathways for models like 4C, Icon, Model C and Perfexion can extend equipment lifecycles and offer more predictable total cost profiles, making their offerings more attractive to fiscally conservative procurement teams.

Practical strategic measures for vendors and providers to align product innovation, commercial flexibility, and service capability to accelerate adoption and mitigate policy risks

Industry leaders should adopt a multi-pronged strategy to navigate clinical, commercial and policy headwinds while capturing growth opportunities in radiosurgery. First, align product roadmaps with clinician needs by prioritizing frameless workflows, enhanced imaging integration and planning automation that reduce treatment times and expand eligible patient populations. Investing in continuous clinical evidence generation and peer-reviewed outcome data will strengthen procurement narratives and support inclusion in standardized care pathways.

Second, optimize commercial models by expanding flexible financing, upgrade-as-a-service offerings and localized inventory strategies to mitigate tariff-driven cost volatility and shorten implementation timelines. Strengthen channel partnerships by defining clear roles for direct sales teams versus local and national distributors, ensuring consistent service level agreements and knowledge transfer. Finally, invest in workforce enablement and digital service capabilities such as remote diagnostics and training platforms to improve uptime, support faster onboarding of new users and reinforce long-term customer relationships.

A transparent mixed-methods research approach combining stakeholder interviews and secondary evidence synthesis to validate clinical and commercial insights

This analysis synthesizes insights derived from a mixed-methods research approach that blends primary stakeholder engagement with rigorous secondary evidence synthesis. Primary engagement included structured interviews and discussions with clinical leaders, procurement specialists, clinical engineers and vendor account executives to capture frontline perspectives on device selection criteria, workflow priorities and contractual preferences. These conversations informed qualitative understanding of adoption barriers, service expectations and upgrade rationales across different facility types.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, policy announcements and publicly available product documentation to validate clinical performance claims and situate technology evolution within regulatory contexts. The methodology incorporated cross-validation between primary insights and secondary sources to identify convergent themes and to flag areas requiring closer monitoring. Analytical rigor was maintained through iterative triangulation, ensuring that conclusions reflect consistent patterns observed across multiple information streams and stakeholder groups.

A consolidated closing synthesis highlighting strategic priorities, supply chain resilience, and evidence alignment to support sustainable radiosurgery adoption

In closing, the Gamma Knife domain is at an inflection point where clinical innovation, supply chain dynamics and evolving procurement models intersect. Providers and vendors that proactively adapt to frameless workflows, invest in interoperable planning and imaging solutions, and deploy flexible commercial models will be better positioned to capture emerging demand and strengthen long-term partnerships. Tariff-induced cost pressures underscore the importance of supply chain diversification and local service capabilities to preserve implementation timelines and predictability of total lifecycle costs.

Looking ahead, success will hinge on aligning clinical evidence generation with procurement narratives, leveraging segmentation insights to tailor channel and product strategies, and building resilient service infrastructures that keep systems operational and clinicians confident. Institutions that integrate these considerations into capital planning and clinical strategy will be well-equipped to expand access to precision radiosurgery while maintaining fiscal discipline and operational excellence.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of frameless stereotactic techniques to improve patient comfort and workflow efficiency
  • 5.2. Integration of artificial intelligence algorithms for real time dose planning and adaptive treatment optimization
  • 5.3. Expansion of gamma knife indications to include non malignant neurological disorders such as trigeminal neuralgia
  • 5.4. Development of focused beam collimation technologies to reduce radiation exposure to healthy brain tissue
  • 5.5. Growing preference for outpatient gamma knife radiosurgery due to cost reduction and shorter recovery times
  • 5.6. Collaborative research initiatives between academic centers and manufacturers to advance precision radiosurgery outcomes
  • 5.7. Regulatory approvals and reimbursement reforms facilitating wider gamma knife access in emerging markets

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gamma Knife Market, by Distribution Channel

  • 8.1. Direct Sales
    • 8.1.1. E Commerce
    • 8.1.2. Oem Sales Team
  • 8.2. Distributor
    • 8.2.1. Local Distributors
    • 8.2.2. National Distributors

9. Gamma Knife Market, by End User

  • 9.1. Ambulatory Surgical Centers
    • 9.1.1. Radiology Centers
    • 9.1.2. Surgical Centers
  • 9.2. Hospitals
    • 9.2.1. Community Hospitals
    • 9.2.2. Tertiary Care Hospitals
  • 9.3. Specialty Clinics
    • 9.3.1. Neurosurgery Centers
    • 9.3.2. Oncology Clinics

10. Gamma Knife Market, by Application

  • 10.1. Brain Tumors
    • 10.1.1. Metastatic Brain Tumors
    • 10.1.2. Primary Brain Tumors
  • 10.2. Functional Disorders
    • 10.2.1. Movement Disorders
    • 10.2.2. Trigeminal Neuralgia
  • 10.3. Vascular Malformations
    • 10.3.1. Arteriovenous Malformations
    • 10.3.2. Cavernous Malformations

11. Gamma Knife Market, by Product Type

  • 11.1. 4C
    • 11.1.1. New Units
    • 11.1.2. Upgrades
  • 11.2. Icon
    • 11.2.1. New Units
    • 11.2.2. Upgrades
  • 11.3. Model C
    • 11.3.1. New Units
    • 11.3.2. Upgrades
  • 11.4. Perfexion
    • 11.4.1. New Units
    • 11.4.2. Upgrades

12. Gamma Knife Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gamma Knife Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gamma Knife Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Elekta AB (publ)
    • 15.3.2. Accuray Incorporated
    • 15.3.3. Siemens Healthineers AG
    • 15.3.4. Varian Medical Systems, Inc.
    • 15.3.5. Brainlab AG
    • 15.3.6. ViewRay, Inc.
    • 15.3.7. Nordion Inc.
    • 15.3.8. Mevion Medical Systems, Inc.
    • 15.3.9. IBA Group S.A.
    • 15.3.10. Shinva Medical Instrument Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GAMMA KNIFE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GAMMA KNIFE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS GAMMA KNIFE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA GAMMA KNIFE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL GAMMA KNIFE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GAMMA KNIFE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. GAMMA KNIFE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GAMMA KNIFE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GAMMA KNIFE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GAMMA KNIFE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GAMMA KNIFE MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GAMMA KNIFE MARKET SIZE, BY OEM SALES TEAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GAMMA KNIFE MARKET SIZE, BY LOCAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GAMMA KNIFE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GAMMA KNIFE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GAMMA KNIFE MARKET SIZE, BY RADIOLOGY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GAMMA KNIFE MARKET SIZE, BY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GAMMA KNIFE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GAMMA KNIFE MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GAMMA KNIFE MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEUROSURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GAMMA KNIFE MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GAMMA KNIFE MARKET SIZE, BY METASTATIC BRAIN TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GAMMA KNIFE MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GAMMA KNIFE MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL GAMMA KNIFE MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL GAMMA KNIFE MARKET SIZE, BY CAVERNOUS MALFORMATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL GAMMA KNIFE MARKET SIZE, BY 4C, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL GAMMA KNIFE MARKET SIZE, BY ICON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL GAMMA KNIFE MARKET SIZE, BY MODEL C, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL GAMMA KNIFE MARKET SIZE, BY PERFEXION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL GAMMA KNIFE MARKET SIZE, BY NEW UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL GAMMA KNIFE MARKET SIZE, BY UPGRADES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL GAMMA KNIFE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL GAMMA KNIFE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS GAMMA KNIFE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS GAMMA KNIFE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS GAMMA KNIFE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS GAMMA KNIFE MARKET SIZE, BY 4C, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS GAMMA KNIFE MARKET SIZE, BY ICON, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS GAMMA KNIFE MARKET SIZE, BY MODEL C, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2024 (USD MILLION)
  • TABLE 312. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2025-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2024 (USD MILLION)
  • TABLE 316. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY 4C, 2025-2032 (USD MILLION)
  • TABLE 317. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY ICON, 2018-2024 (USD MILLION)
  • TABLE 318. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY ICON, 2025-2032 (USD MILLION)
  • TABLE 319. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2018-2024 (USD MILLION)
  • TABLE 320. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY MODEL C, 2025-2032 (USD MILLION)
  • TABLE 321. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2018-2024 (USD MILLION)
  • TABLE 322. NORTH AMERICA GAMMA KNIFE MARKET SIZE, BY PERFEXION, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DIRECT SALES, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY DISTRIBUTOR, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 334. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 335. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 336. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 337. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 338. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 339. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 340. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 341. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2018-2024 (USD MILLION)
  • TABLE 342. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY BRAIN TUMORS, 2025-2032 (USD MILLION)
  • TABLE 343. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 344. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY FUNCTIONAL DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 345. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2018-2024 (USD MILLION)
  • TABLE 346. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY VASCULAR MALFORMATIONS, 2025-2032 (USD MILLION)
  • TABLE 347. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 348. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 349. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY 4C, 2018-2024 (USD MILLION)
  • TABLE 350. LATIN AMERICA GAMMA KNIFE MARKET SIZE, BY 4C, 2025-2032 (USD MILLION)
  • TABLE 351. LATIN AMERICA GAMMA KNIFE MARKET SI